Who invested in CYTIMMUNE SCIENCES

5 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$8.2Mraised across 5 rounds since 2010, from 5 sources

$1.0MDebt$5.4MVenture$400KSeries C$690KVenture$748KVenture

Latest round: Venture, $748KAug 2015
Biggest round: $5.4MVenture · Apr 2014
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201020112012201320142015

$1.0MDebt$5.4MVenture$400KSeries C$748KVenture

First round: Debt, $1.0M
Biggest round: $5.4M
Usual gap between rounds: 11 months

The rounds

Aug 2015
Venture$748K
No investor was named in the report.
From a historical funding recordSEC filing: $748K sold, first sale Aug 2015
Sept 2014
Venture$690K
No investor was named in the report.
From a historical funding recordSEC filing: $690K sold, first sale Sept 2014
May 2014
Series C$400K1 new
- Maryland Venture Fund
From a historical funding recordSEC filing: $400K sold, first sale May 2014
Apr 2014
Venture$5.4M
No investor was named in the report.
From a historical funding recordSEC filing: $5.4M sold, first sale Mar 2014
Jan 2010
Debt$1.0M
No investor was named in the report.
Reported by sec.govSEC filing: $1.0M sold, first sale Sept 2009